Clinical Trial Update: Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the incidence of chemotherapy-induced nausea and vomiting with docetaxel-cyclophosphamide in early breast cancer; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• docetaxel-cyclophosphamide

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2019-09-27